Annex
United Kingdom
The following entry shall be added at the end of the table in Annex I to Directive 91/414/EEC.
Further details on identity and specification of active substance are provided in the review report.’
‘No Common name, identification numbers IUPAC name Purityf1 Entry into force Expiration of inclusion Specific provisions 143 Fenamiphos
CAS No 22224-92-6
CIPAC No 692
(RS)-ethyl 4-methylthio-m-tolyl isopropyl-phosphoramidate ≥ 940 g/kg 1 August 2007 31 July 2017 PART A
Only uses as nematicide applied by drip irrigation in greenhouses with permanent structure may be authorised.
PART B
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on fenamiphos, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 14 July 2006 shall be taken into account.
In this overall assessment:
Member States must pay particular attention to the protection of aquatic organisms, soil non-target organisms and groundwater in vulnerable situations.
Conditions of authorisation should include risk mitigation measures and monitoring programmes should be initiated to verify potential groundwater contamination in vulnerable zones, where appropriate.
144 Ethephon
CAS No 16672-87-0
CIPAC No 373
2-chloroethyl-phosphonic acid ≥ 910 g/kg (technical material — TC)
The manufacturing impurities MEPHA (Mono 2-chloroethyl ester, 2-chloroethyl phosphonic acid) and 1,2-Dichloroethane are of toxicological concern and must not exceed respectively 20 g/kg and 0,5 g/kg in the technical material.
1 August 2007 31 July 2017 PART A
Only uses as plant growth regulator may be authorised.
PART B
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on ethephon, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 14 July 2006 shall be taken into account.
Annotations
Footnotes
- f1
-
Further details on identity and specification of active substance are provided in the review report.’